Search Results 551-560 of 17330 for Cyclophosphamide

  1. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Treatment with lymphocyte-depleting therapies (eg, Campath, anti-CD4, cladribine, rituximab, ocrelizumab, cyclophosphamide, mitoxantrone, total body ...

  2. Articaine (ophthalmic route) - Side effects & uses - Mayo Clinic

    Cyclophosphamide; Dapsone; Dyclonine Hydrochloride; Erythrityl Tetranitrate; Flutamide; Fosphenytoin; Furosemide; Hydroxyurea; Ifosfamide; Indapamide ...

  3. Clinical trials - Oncology (Medical)

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  4. Clinical trials - Oncology (Medical)

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

  5. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or ...

  6. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  7. Quantitative Assessment of Skin and Liver of Patients with Diffuse Systemic Sclerosis Using Shear-Wave Ultrasound Elastography - Mayo Clinic

    ... cyclophosphamide, or on the newly approved antifibrotic medication nintedanib. Exclusion Criteria: Previous or planned hematopoietic stem cell ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to collect medical and personal histories, blood and/or tumor tissue samples from patients who are long-term survivors of lung ...

  9. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells.

  10. Mayo Clinic launches Cardiac Sarcoidosis Clinic

    Antimetabolites such as methotrexate, azathioprine, leflunomide, mycophenolate mofetil and cyclophosphamide have been used as second line agents. If the ...